Akoya Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Akoya Biosciences, Inc. (Nasdaq: AKYA) has announced its participation in the 40th Annual J.P. Morgan Healthcare Conference, scheduled for January 13, 2022, at 9:00 a.m. ET. Brian McKelligon, CEO, will present the company's insights and developments. Investors can access both live and archived webcasts of this event through the Akoya website. As a leader in spatial biology, Akoya aims to enhance understanding of human health and disease through its innovative single-cell imaging solutions, including the CODEX® and Phenoptics™ platforms.

MARLBOROUGH, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company^®, today announced that it will be virtually participating in the 40^th Annual J.P. Morgan Healthcare Conference.

Brian McKelligon, CEO, is scheduled to present on Thursday, January 13^th, 2022 at 9:00 a.m. ET.

A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences
As The Spatial Biology Company^®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX^® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.

Investor Contact:
Priyam Shah
Akoya Biosciences
investors@akoyabio.com

Media Contact:
Michelle Linn
Bioscribe, Inc.
774-696-3803
michelle@bioscribe.com

FAQ

When is Akoya Biosciences presenting at the J.P. Morgan Healthcare Conference?

Akoya Biosciences is scheduled to present on January 13, 2022, at 9:00 a.m. ET.

How can I watch Akoya Biosciences' presentation at the conference?

You can watch the live and archived webcast on the 'Investors' section of the Akoya website.

What is the focus of Akoya Biosciences as a company?

Akoya Biosciences specializes in spatial biology, offering solutions for single-cell imaging to understand cell interactions in disease and treatment response.

What platforms does Akoya Biosciences offer?

Akoya offers the CODEX® and Phenoptics™ platforms for single-cell imaging solutions.

Who is the CEO of Akoya Biosciences?

The CEO of Akoya Biosciences is Brian McKelligon.